(VIANEWS) - National Health Investors (NHI), MPLX LP (MPLX), Allete (ALE) are the highest payout ratio stocks on this list.
Here's the data we've collected of stocks with a high payout ratio up to now. The payout ratio in itself isn't a promise of a future good investment but it's an indicator of whether dividends are being paid and how the company chooses to issue them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. National Health Investors (NHI)
195.65% Payout Ratio
National Health Investors, Inc. was founded in 1991. It is a real-estate investment trust that specializes in the sale-leaseback, joint venture, mortgage, mezzanine and mortgage financing of senior housing, medical investments, and need-driven, discretionary senior housing.
Volume
Today's last reported volume for National Health Investors is 251598, 5.88% below its average volume of 267322.
As claimed by Morningstar, Inc., the next dividend payment is on Jun 28, 2022, the estimated forward annual dividend rate is 3.6 and the estimated forward annual dividend yield is 6.11%.
National Health Investors's sales growth this year is expected to be negative 2.9% and 7.8% for next year.
Year-on-year quarterly revenue growth declined by 10.6%, now sitting on 288.45M for the twelve trailing months.
National Health Investors's sales growth for the current quarter is 0.5%. The company's growth estimates for the ongoing quarter and the next is negative 14.1% and 7.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.56%.
Volatility
National Health Investors's last day, week, and month's current intraday variation average was 0.44%, 0.60%, and 1.35%, respectively.
National Health Investors's highest amplitude of average volatility was 2.21% (day), 2.22% (last week), and 2.99% (last month), respectively.
National Health Investors's Stock Yearly Top and Bottom Value
National Health Investors's stock is valued at $59.20 at 14:23 EST, way below its 52-week high of $69.23 and way above its 52-week low of $50.22.
National Health Investors's Moving Average
National Health Investors's worth is above its 50-day moving average of $56.01 and higher than its 200-day moving average of $56.32.2. MPLX LP (MPLX)
107.42% Payout Ratio
MPLX LP is a midstream infrastructure operator and logistics asset owner based primarily in the United States.
Volume
Today's last reported volume for MPLX LP is 940250, 52.04% below its average volume of 1960730.
As claimed by Morningstar, Inc., the next dividend payment is on Aug 4, 2021, the estimated forward annual dividend rate is 2.75 and the estimated forward annual dividend yield is 9.78%.
MPLX LP's sales growth this year is anticipated to be 22.1% and 1.4% for next year.
Year-on-year quarterly revenue growth grew by 16.9%, now sitting on 8.94B for the twelve trailing months.
MPLX LP's sales growth is 13.8% for the present quarter and 4.6% for the next. The company's growth estimates for the present quarter and the next is 16.4% and 14.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 20.27%.
Volatility
MPLX LP's last day, week, and month's current intraday variation average was 0.74%, 1.42%, and 1.10%, respectively.
MPLX LP's highest amplitude of average volatility was 1.90% (day), 1.93% (last week), and 1.90% (last month), respectively.
MPLX LP's Stock Yearly Top and Bottom Value
MPLX LP's stock is valued at $34.39 at 14:23 EST, above its 52-week high of $32.26.
MPLX LP's Moving Average
MPLX LP's worth is way higher than its 50-day moving average of $30.31 and way higher than its 200-day moving average of $28.51.3. Allete (ALE)
72.99% Payout Ratio
ALLETE, Inc. is an energy company.
Volume
Today's last reported volume for Allete is 64369, 82.16% below its average volume of 360860.
As claimed by Morningstar, Inc., the next dividend payment is on May 12, 2022, the estimated forward annual dividend rate is 2.6 and the estimated forward annual dividend yield is 4.31%.
Allete's sales growth this year is expected to be negative 0.7% and 1.8% for next year.
Year-on-year quarterly revenue growth grew by 24.5%, now sitting on 1.42B for the twelve trailing months.
Allete's sales growth is 18.3% for the present quarter and negative 0.9% for the next. The company's growth estimates for the present quarter and the next is 32.3% and 22.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.8%.
Volatility
Allete's last day, week, and month's current intraday variation average was 0.08%, 0.46%, and 1.07%, respectively.
Allete's highest amplitude of average volatility was 2.02% (day), 1.89% (last week), and 2.54% (last month), respectively.
Allete's Stock Yearly Top and Bottom Value
Allete's stock is valued at $61.98 at 14:23 EST, way below its 52-week high of $73.10 and higher than its 52-week low of $56.84.
Allete's Moving Average
Allete's value is under its 50-day moving average of $62.70 and under its 200-day moving average of $63.40.4. Centrais Elc Braz Pfb B Elbras (EBR)
69.61% Payout Ratio
Centrais ElA(c).tricas Brasileiras S.A. is a subsidiary of Eletrobras that engages in generation, transmission and distribution in Brazil.
Volume
Today's last reported volume for Centrais Elc Braz Pfb B Elbras is 4064830, 87.22% above its average volume of 2171050.
According to Morningstar, Inc., the next dividend payment is on May 3, 2022, the estimated forward annual dividend rate is 0.15 and the estimated forward annual dividend yield is 1.84%.
Centrais Elc Braz Pfb B Elbras's sales growth this year is expected to be 21.6% and a negative 10.9% for next year.
Year-on-year quarterly revenue growth grew by 20.8%, now sitting on 37.62B for the twelve trailing months.
Centrais Elc Braz Pfb B Elbras's sales growth for the current quarter is 147.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.61%.
Volatility
Centrais Elc Braz Pfb B Elbras's last day, week, and month's current intraday variation average was 0.91%, 1.33%, and 2.16%, respectively.
Centrais Elc Braz Pfb B Elbras's highest amplitude of average volatility was 3.12% (day), 3.14% (last week), and 3.57% (last month), respectively.
Centrais Elc Braz Pfb B Elbras's Stock Yearly Top and Bottom Value
Centrais Elc Braz Pfb B Elbras's stock is valued at $8.96 at 14:24 EST, under its 52-week high of $9.61 and way above its 52-week low of $5.17.
Centrais Elc Braz Pfb B Elbras's Moving Average
Centrais Elc Braz Pfb B Elbras's worth is higher than its 50-day moving average of $8.36 and way higher than its 200-day moving average of $6.99.5. STERIS (STE)
47.9% Payout Ratio
STERIS plc offers infection prevention products and procedures worldwide.
Volume
Today's last reported volume for STERIS is 229654, 50.91% below its average volume of 467879.
According to Morningstar, Inc., the next dividend payment is on Sep 1, 2021, the estimated forward annual dividend rate is 1.72 and the estimated forward annual dividend yield is 0.8%.
STERIS's sales growth this year is anticipated to be 47.6% and 10.3% for next year.
Year-on-year quarterly revenue growth grew by 44.8%, now sitting on 3.41B for the twelve trailing months.
STERIS's sales growth for the current quarter is 59.3%. The company's growth estimates for the ongoing quarter and the next is 23% and 13.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.67%.
Volatility
STERIS's last day, week, and month's current intraday variation average was 0.31%, 1.55%, and 2.03%, respectively.
STERIS's highest amplitude of average volatility was 1.73% (day), 2.62% (last week), and 2.73% (last month), respectively.
STERIS's Stock Yearly Top and Bottom Value
STERIS's stock is valued at $226.17 at 14:24 EST, under its 52-week high of $237.35 and way above its 52-week low of $170.36.
STERIS's Moving Average
STERIS's worth is under its 50-day moving average of $226.39 and higher than its 200-day moving average of $209.62.6. LeMaitre Vascular (LMAT)
36.69% Payout Ratio
LeMaitre Vascular, Inc. develops, markets, sales, supports, and services medical devices and implant for treatment of peripheral vein disease.
Volume
Today's last reported volume for LeMaitre Vascular is 76147, 49.35% below its average volume of 150366.
As claimed by Morningstar, Inc., the next dividend payment is on May 15, 2022, the estimated forward annual dividend rate is 0.5 and the estimated forward annual dividend yield is 1.15%.
LeMaitre Vascular's sales growth this year is expected to be 5.2% and 7.4% for next year.
Year-on-year quarterly revenue growth grew by 10.2%, now sitting on 158.1M for the twelve trailing months.
LeMaitre Vascular's sales growth is 6.4% for the current quarter and 4.7% for the next. The company's growth estimates for the present quarter and the next is negative 37.5% and 3.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.41%.
Volatility
LeMaitre Vascular's last day, week, and month's current intraday variation average was 1.06%, 2.68%, and 2.85%, respectively.
LeMaitre Vascular's highest amplitude of average volatility was 3.99% (day), 4.65% (last week), and 5.18% (last month), respectively.
LeMaitre Vascular's Stock Yearly Top and Bottom Value
LeMaitre Vascular's stock is valued at $44.80 at 14:24 EST, way under its 52-week high of $64.50 and way higher than its 52-week low of $38.32.